Using Apremilast to help treat alcohol use disorder
APREMILAST FOR THE TREATMENT OF ALCOHOL USE DISORDER -- CONTRACT RESEARCH ORGANIZATION STUDY AND DATA MANAGEMENT
This study is looking at how well the medication Apremilast can help people with alcohol use disorder, and if you join, you'll receive the treatment while being carefully monitored to see how it works for you.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Fast Track Drugs and Biol NIH-funded |
| Lab location | 1 site (Gaithersburg, United States) |
| Project ID | NIH-11218300 on NIH RePORTER |
What this research studies
This research focuses on the use of Apremilast, a medication, to treat individuals with alcohol use disorder (AUD). The study involves a Contract Research Organization (CRO) that will coordinate and support clinical trials across various research sites. Patients participating in this research may receive the medication while being closely monitored for safety and effectiveness, with data collected to assess the treatment's impact. The CRO will handle all aspects of the trial, including regulatory support, data analysis, and preparation of study reports.
Who could benefit from this research
Good fit: Ideal candidates for this research are adults diagnosed with alcohol use disorder who are seeking treatment.
Not a fit: Patients who do not have alcohol use disorder or those who are currently undergoing other forms of treatment may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could provide a new treatment option for individuals struggling with alcohol use disorder.
How similar studies have performed: Previous research has shown promise in using medications for treating alcohol use disorder, making this approach a continuation of established methods.
Where this research is happening
Gaithersburg, United States
- Fast Track Drugs and Biol — Gaithersburg, United States (Active)
Researchers
- Principal investigator: Ransom, Janet — Fast Track Drugs and Biol
- Study coordinator: Ransom, Janet
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.